Amedeo Smart

Free Medical Literature Service


 

Amedeo

Cytomegalovirus Infection

  Free Subscription

Articles published in
J Infect Dis
    July 2021
  1. HAMILTON EM, Allen NE, Mentzer AJ, Littlejohns TJ, et al
    Human cytomegalovirus and risk of incident cardiovascular disease in UK Biobank.
    J Infect Dis. 2021 Jul 19. pii: 6323934. doi: 10.1093.
    >> Share

  2. POLONI C, Szyf M, Cheishvili D, Tsoukas CM, et al
    Are the healthy vulnerable? Cytomegalovirus seropositivity in healthy adults is associated with accelerated epigenetic age and immune-dysregulation.
    J Infect Dis. 2021 Jul 13. pii: 6320592. doi: 10.1093.
    >> Share

    April 2021
  3. STERN A, Su Y, Dumke H, Fang J, et al
    CMV viral load kinetics predict CMV end-organ disease and mortality after hematopoietic cell transplant (HCT).
    J Infect Dis. 2021 Apr 17. pii: 6232014. doi: 10.1093.
    >> Share

  4. DIOVERTI PRONO MV, Avery RK
    Viral load kinetics: a way to assess cumulative effects of CMV on hematopoietic stem cell transplant recipients.
    J Infect Dis. 2021 Apr 17. pii: 6232022. doi: 10.1093.
    >> Share

    March 2021
  5. SINGH N, Winston DJ, Razonable RR, Lyon GM, et al
    Unexpected CMV replication kinetics in CMV- donor seropositive recipient seronegative liver transplant recipients receiving preemptive antiviral therapy.
    J Infect Dis. 2021 Mar 23. pii: 6182482. doi: 10.1093.
    >> Share

    December 2020
  6. ALTAF M, Lineburg K, Crooks P, Rehan S, et al
    Pre-transplant cytomegalovirus-specific cellular immunity and risk of viral reactivation following lung transplantation: a prospective cohort study.
    J Infect Dis. 2020 Dec 4. pii: 6019998. doi: 10.1093.
    >> Share

    November 2020
  7. DONADEU L, Revilla-Lopez E, Jarque M, Crespo E, et al
    CMV-specific Cell-Mediated Immunity Predicts High level of CMV Replication after Prophylaxis withdrawal in Lung Transplant Recipients.
    J Infect Dis. 2020 Nov 27. pii: 6007492. doi: 10.1093.
    >> Share

  8. IMLAY H, Dasgupta S, Boeckh M, Stapleton RD, et al
    Risk Factors for Cytomegalovirus Reactivation and Association with Outcomes in Critically Ill Adults with Sepsis: A Pooled Analysis of Prospective Studies.
    J Infect Dis. 2020 Nov 7. pii: 5959850. doi: 10.1093.
    >> Share

    October 2020
  9. SLYKER JA, Guthrie B, Pankau M, Tapia K, et al
    Cytomegalovirus and Epstein-Barr virus viremia are associated with HIV DNA levels in the reservoir of Kenyan infants on antiretroviral therapy.
    J Infect Dis. 2020 Oct 16. pii: 5926738. doi: 10.1093.
    >> Share

  10. COX KS, Zhang L, Freed DC, Tang A, et al
    Functional Evaluation and Genetic Evolution of Human T-cell Responses after Vaccination with a Conditionally Replication-Defective Cytomegalovirus Vaccine.
    J Infect Dis. 2020 Oct 8. pii: 5919748. doi: 10.1093.
    >> Share

    September 2020
  11. NIKOLICH-ZUGICH J
    Cytomegalovirus and Your Health: Not a Matter of the Heart, Nor of Life and Death.
    J Infect Dis. 2020 Sep 10. pii: 5903620. doi: 10.1093.
    >> Share

  12. CHEN S, Pawelec G, Trompet S, Goldeck D, et al
    Associations of Cytomegalovirus Infection With All-Cause and Cardiovascular Mortality in Multiple Observational Cohort Studies of Older Adults.
    J Infect Dis. 2020 Sep 10. pii: 5903621. doi: 10.1093.
    >> Share

    August 2020
  13. PAEZ-VEGA A, Cantisan S, Aguera ML, Suner M, et al
    Pretransplant CMV-specific T-cell immunity but not dose of antithymocyte globulin is associated with recovery of specific immunity after kidney transplantation.
    J Infect Dis. 2020 Aug 11. pii: 5890921. doi: 10.1093.
    >> Share

    July 2020
  14. SINGH N, Winston DJ, Razonable RR, Lyon GM, et al
    Risk factors for viremia in CMV- recipient seronegative donor seropositive liver transplant recipients who receive preemptive antiviral therapy.
    J Infect Dis. 2020 Jul 29. pii: 5878043. doi: 10.1093.
    >> Share

  15. CHOU S, Song K, Wu J, Bo T, et al
    Drug resistance mutations and associated phenotypes detected in clinical trials of maribavir for treatment of cytomegalovirus infection.
    J Infect Dis. 2020 Jul 29. pii: 5877931. doi: 10.1093.
    >> Share

  16. HASING ME, Pang XL, Mabilangan C, Preiksaitis JK, et al
    Donor cytomegalovirus transmission patterns in solid organ transplant recipients with primary infection.
    J Infect Dis. 2020 Jul 24. pii: 5876001. doi: 10.1093.
    >> Share

  17. VIETZEN H, Gorzer I, Honsig C, Jaksch P, et al
    Human Cytomegalovirus (HCMV)-Specific Antibody Response and Development of Antibody-Dependent Cellular Cytotoxicity Against HCMV After Lung Transplantation.
    J Infect Dis. 2020;222:417-427.
    >> Share

  18. KAMINSKI H, Menard C, El Hayani B, Adjibabi AN, et al
    Characterization of a unique gammadelta T cell subset as a specific marker of CMV infection severity.
    J Infect Dis. 2020 Jul 5. pii: 5867506. doi: 10.1093.
    >> Share

    April 2020
  19. SCHWENDINGER M, Thiry G, De Vos B, Leroux-Roels G, et al
    A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus.
    J Infect Dis. 2020 Apr 21. pii: 5821369. doi: 10.1093.
    >> Share

  20. ALI A, Chiuppesi F, Nguyen M, Hausner MA, et al
    Chimeric Antigen Receptors Targeting Human Cytomegalovirus.
    J Infect Dis. 2020 Apr 13. pii: 5819787. doi: 10.1093.
    >> Share

    March 2020
  21. IMLAY H, Limaye AP
    Current Understanding of Cytomegalovirus Reactivation in Critical Illness.
    J Infect Dis. 2020;221.
    >> Share

  22. LAUGHLIN C, Chakhtoura N, Beisel C, Dempsey W, et al
    Cytomegalovirus Meeting Summary.
    J Infect Dis. 2020;221.
    >> Share

  23. RAZONABLE RR, Inoue N, Pinninti SG, Boppana SB, et al
    Clinical Diagnostic Testing for Human Cytomegalovirus Infections.
    J Infect Dis. 2020;221.
    >> Share

  24. HAIDAR G, Boeckh M, Singh N
    Cytomegalovirus Infection in Solid Organ and Hematopoietic Cell Transplantation: State of the Evidence.
    J Infect Dis. 2020;221.
    >> Share

  25. KRAUSE PR, Roberts J
    Scientific and Regulatory Considerations for Efficacy Studies of Cytomegalovirus Vaccines.
    J Infect Dis. 2020;221.
    >> Share

  26. PLOTKIN SA
    Preventing Infection by Human Cytomegalovirus.
    J Infect Dis. 2020;221.
    >> Share

  27. ACOSTA E, Bowlin T, Brooks J, Chiang L, et al
    Advances in the Development of Therapeutics for Cytomegalovirus Infections.
    J Infect Dis. 2020;221.
    >> Share

  28. MUSSI-PINHATA MM, Yamamoto AY
    Natural History of Congenital Cytomegalovirus Infection in Highly Seropositive Populations.
    J Infect Dis. 2020;221.
    >> Share

  29. ROARK HK, Jenks JA, Permar SR, Schleiss MR, et al
    Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development.
    J Infect Dis. 2020;221.
    >> Share

  30. KABANI N, Ross SA
    Congenital Cytomegalovirus Infection.
    J Infect Dis. 2020;221.
    >> Share

  31. BRITT WJ
    Human Cytomegalovirus Infection in Women With Preexisting Immunity: Sources of Infection and Mechanisms of Infection in the Presence of Antiviral Immunity.
    J Infect Dis. 2020;221.
    >> Share

  32. PLOTKIN SA, Wang D, Oualim A, Diamond DJ, et al
    The Status of Vaccine Development Against the Human Cytomegalovirus.
    J Infect Dis. 2020;221.
    >> Share

  33. NELSON CS, Baraniak I, Lilleri D, Reeves MB, et al
    Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease.
    J Infect Dis. 2020;221.
    >> Share

  34. HODOWANEC AC, Pikis A, Singer ME
    The Development of Therapeutics for the Treatment and Prevention of CMV Disease in the Transplant Population: A Regulatory Perspective.
    J Infect Dis. 2020;221.
    >> Share

  35. LANZIERI TM, Gastanaduy PA, Gambhir M, Plotkin SA, et al
    Review of Mathematical Models of Vaccination for Preventing Congenital Cytomegalovirus Infection.
    J Infect Dis. 2020;221.
    >> Share

  36. GRIFFITHS P, Hughes B
    Choice of Study Populations for Vaccines.
    J Infect Dis. 2020;221.
    >> Share

    February 2020
  37. BEHRENS GA, Brehm M, Gross R, Heider J, et al
    Non-invasive determination of CMV serostatus from dried buccal swab samples: assay development, validation and application to 1.2 million samples.
    J Infect Dis. 2020 Feb 13. pii: 5735315. doi: 10.1093.
    >> Share

    December 2019
  38. JO H, Kwon DE, Han SH, Min SY, et al
    De Novo Genotypic Heterogeneity in the UL56 Region in Cytomegalovirus-infected Tissues: Implications for Primary Letermovir Resistance.
    J Infect Dis. 2019 Dec 5. pii: 5658434. doi: 10.1093.
    >> Share

    November 2019
  39. JAMES SH
    Letermovir Resistance in Hematopoietic Stem Cell Transplant Recipients: The Risks Associated with Cytomegalovirus Prophylaxis.
    J Infect Dis. 2019 Nov 29. pii: 5645460. doi: 10.1093.
    >> Share

  40. DOUGLAS CM, Barnard R, Holder D, Leavitt R, et al
    Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients.
    J Infect Dis. 2019 Nov 29. pii: 5645458. doi: 10.1093.
    >> Share

  41. ZAMORA D, Krantz EM, Green ML, Joncas-Schronce L, et al
    The Cytomegalovirus Humoral Response Against Epithelial Cell Entry-mediated Infection in the Primary Infection Setting after Hematopoietic Cell Transplantation.
    J Infect Dis. 2019 Nov 18. pii: 5627782. doi: 10.1093.
    >> Share

  42. SMITH C, Moraka NO, Ibrahim M, Moyo S, et al
    HIV Exposure but Not Early CMV Infection is Associated with Increased Hospitalization and Decreased Memory T-cell Responses to Tetanus Vaccine.
    J Infect Dis. 2019 Nov 10. pii: 5618838. doi: 10.1093.
    >> Share

  43. STOCKDALE L, Nash S, Farmer R, Raynes J, et al
    Cytomegalovirus antibody responses associated with increased risk of TB disease in Ugandan adults.
    J Infect Dis. 2019 Nov 5. pii: 5613526. doi: 10.1093.
    >> Share

    October 2019
  44. ROSS S, Pati P, Jensen TL, Goll JB, et al
    Cytomegalovirus genetic diversity following primary infection.
    J Infect Dis. 2019 Oct 8. pii: 5583881. doi: 10.1093.
    >> Share

    August 2019
  45. MEESING A, Germer JJ, Yao JD, Gartner ML, et al
    Differences in Duration and Degree of Cytomegalovirus DNAemia Observed with Two Standardized Quantitative Nucleic Acid Tests and Implications for Clinical Care.
    J Infect Dis. 2019 Aug 31. pii: 5557844. doi: 10.1093.
    >> Share

    July 2019
  46. EVENTOV-FRIEDMAN S, Manor H, Bar-Oz B, Averbuch D, et al
    Saliva real time polymerase chain reaction for targeted screening of congenital cytomegalovirus infection.
    J Infect Dis. 2019 Jul 15. pii: 5532655. doi: 10.1093.
    >> Share

  47. ADLER SP, Lewis N, Conlon A, Christiansen MP, et al
    Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects.
    J Infect Dis. 2019;220:411-419.
    >> Share

    June 2019
  48. PIRET J, Schibler M, Pham VD, Hantz S, et al
    Compartmentalization of a Multidrug-Resistant Cytomegalovirus UL54 Mutant in a Stem Cell Transplant Recipient with Encephalitis.
    J Infect Dis. 2019 Jun 13. pii: 5519111. doi: 10.1093.
    >> Share

    May 2019
  49. SACCOCCIO FM, Jenks JA, Itell HL, Li SH, et al
    Humoral Immune Correlates for Prevention of Postnatal Cytomegalovirus Acquisition.
    J Infect Dis. 2019 May 20. pii: 5492326. doi: 10.1093.
    >> Share

  50. SUAREZ NM, Wilkie GS, Hage E, Camiolo S, et al
    Human Cytomegalovirus Genomes Sequenced Directly from Clinical Material: Variation, Multiple-Strain Infection, Recombination and Gene Loss.
    J Infect Dis. 2019 May 2. pii: 5485299. doi: 10.1093.
    >> Share

  51. SUAREZ NM, Musonda KG, Escriva E, Njenga M, et al
    Multiple-Strain Infections of Human Cytomegalovirus with High Genomic Diversity are Common In Breast Milk from HIV-Positive Women in Zambia.
    J Infect Dis. 2019 May 2. pii: 5485308. doi: 10.1093.
    >> Share

    April 2019
  52. LIMAYE AP, Green ML, Edmison BC, Stevens-Ayers T, et al
    Prospective Assessment of Cytomegalovirus Immunity in High-Risk Donor-Seropositive/Recipient-Seronegative Liver Transplant Recipients Receiving Either Preemptive Therapy or Antiviral Prophylaxis.
    J Infect Dis. 2019 Apr 26. pii: 5480166. doi: 10.1093.
    >> Share

  53. KAMINSKI H, Jarque M, Halfon M, Taton B, et al
    Different impact of rATG induction on CMV infection risk in D+R- and R+ KTRs.
    J Infect Dis. 2019 Apr 26. pii: 5480114. doi: 10.1093.
    >> Share

  54. EL HADDAD L, Ariza-Heredia E, Chemaly RF
    Reply to Gimenez et al.
    J Infect Dis. 2019;219:1512-1513.
    >> Share

    February 2019
  55. BARANIAK I, Kern F, Holenya P, Griffiths P, et al
    Original antigenic sin shapes the immunological repertoire evoked by HCMV gB-MF59 vaccine in seropositive recipients.
    J Infect Dis. 2019 Feb 27. pii: 5366424. doi: 10.1093.
    >> Share

    January 2019
  56. MUENCHHOFF M, Adland E, Roider J, Kloverpris H, et al
    Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children.
    J Infect Dis. 2019 Jan 8. pii: 5280900. doi: 10.1093.
    >> Share

    December 2018
  57. GIMENEZ E, Solano C, Luis Pinana J, Poch M, et al
    Cytomegalovirus-specific CD8+ T cell levels at viral DNAemia onset fail to predict the eventual need for preemptive antiviral therapy in allogeneic hematopoietic stem cell transplant recipients.
    J Infect Dis. 2018 Dec 29. pii: 5266810. doi: 10.1093.
    >> Share

  58. MARSICO C, Aban I, Kuo H, James SH, et al
    Blood Viral Load in Symptomatic Congenital Cytomegalovirus Infection.
    J Infect Dis. 2018 Dec 7. pii: 5232568. doi: 10.1093.
    >> Share

    October 2018
  59. EL HADDAD L, Ariza-Heredia E, Shah DP, Jiang Y, et al
    The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients.
    J Infect Dis. 2018 Oct 6. pii: 5122855. doi: 10.1093.
    >> Share

    August 2018
  60. CHANOUZAS D, Sagmeister M, Faustini S, Nightingale P, et al
    Subclinical reactivation of cytomegalovirus drives CD4+CD28null T-cell expansion and impaired immune response to pneumococcal vaccination in ANCA-associated vasculitis.
    J Infect Dis. 2018 Aug 9. pii: 5068409. doi: 10.1093.
    >> Share

    June 2018
  61. PLOTKIN SA
    Seroconversion for Cytomegalovirus Infection during Pregnancy and Fetal Infection in a Highly Seropositive Population: "The BraCHS Study, " by Mussi-Pinhata et al.
    J Infect Dis. 2018 Jun 4. pii: 5032599. doi: 10.1093.
    >> Share

  62. MUSSI-PINHATA MM, Yamamoto AY, Aragon DC, Duarte G, et al
    Seroconversion for Cytomegalovirus infection during pregnancy and fetal infection in a highly seropositive population: "The BraCHS Study".
    J Infect Dis. 2018 Jun 4. pii: 5032598. doi: 10.1093.
    >> Share

    May 2018
  63. JOHNSON EL, Boggavarapu S, Johnson ES, Lal A, et al
    HCMV enhances placental susceptibility and replication of HIV-1 which may facilitate in utero HIV-1 transmission.
    J Infect Dis. 2018 May 31. pii: 5026120. doi: 10.1093.
    >> Share

  64. BURTON CE, Sester M, Robinson JL, Eurich DT, et al
    Assigning Cytomegalovirus (CMV) Status in Children Awaiting Organ Transplant: Viral Shedding, CMV-Specific T-cells and CD27-CD28-CD4+ T-cells.
    J Infect Dis. 2018 May 24. pii: 5003041. doi: 10.1093.
    >> Share

    April 2018
  65. FALK JJ, Winkelmann M, Stohr D, Alt M, et al
    Identification of "elite" blood donors with broad and potent neutralizing activity against the human cytomegalovirus.
    J Infect Dis. 2018 Apr 19. pii: 4976609. doi: 10.1093.
    >> Share

  66. CHENEAU C, Coulon F, Porkolab V, Fieschi F, et al
    Fine-mapping the interaction between DC-SIGN and the cytomegalovirus envelope glycoprotein B.
    J Infect Dis. 2018 Apr 10. pii: 4965770. doi: 10.1093.
    >> Share

    March 2018
  67. SCHLEISS MR
    Searching for a Serological Correlate of Protection for a CMV Vaccine.
    J Infect Dis. 2018 Mar 8. pii: 4924674. doi: 10.1093.
    >> Share

  68. BARANIAK I, Kropff B, McLean GR, Pichon S, et al
    Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine with MF59: Anti-AD2 Levels Correlate with Protection from Viremia.
    J Infect Dis. 2018 Mar 8. pii: 4924673. doi: 10.1093.
    >> Share

    February 2018
  69. MARGOLICK JB, Bream JH, Nilles TL, Li H, et al
    Relationship Between T-Cell Responses to CMV, Markers of Inflammation, and Frailty in HIV-uninfected and HIV-infected Men in the Multicenter AIDS Cohort Study.
    J Infect Dis. 2018 Feb 26. pii: 4909741. doi: 10.1093.
    >> Share

  70. ROSS SA, Michaels MG, Ahmed A, Palmer AL, et al
    Contribution of Breastfeeding to False Positive Saliva PCR for Newborn Congenital Cytomegalovirus Screening.
    J Infect Dis. 2018 Feb 1. pii: 4833232. doi: 10.1093.
    >> Share

    December 2017
  71. HUANG Y, Guo X, Song Q, Wang H, et al
    Cytomegalovirus shedding in healthy seropositive female college students: a six-month longitudinal study.
    J Infect Dis. 2017 Dec 25. pii: 4774530. doi: 10.1093.
    >> Share

  72. GUBERINA H, da Silva Nardi F, Tomoya Michita R, Dolff S, et al
    Susceptibility of HLA-E*01:03 allele carriers to develop Cytomegalovirus replication after living-donor kidney transplantation.
    J Infect Dis. 2017 Dec 8. pii: 4712146. doi: 10.1093.
    >> Share

  73. VIETZEN H, Pollak K, Honsig C, Jaksch P, et al
    NKG2C Deletion is a Risk Factor for Human Cytomegalovirus-Viremia and Disease after Lung Transplantation.
    J Infect Dis. 2017 Dec 6. pii: 4695493. doi: 10.1093.
    >> Share

    September 2017
  74. PEI XY, Zhao XY, Chang YJ, Liu J, et al
    Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for Cytomegalovirus.
    J Infect Dis. 2017 Sep 23. doi: 10.1093.
    >> Share

  75. DOWD JB, Bosch JA, Steptoe A, Jayabalasingham B, et al
    Persistent Herpesvirus Infections and Telomere Attrition Over 3 Years in the Whitehall II Cohort.
    J Infect Dis. 2017;216:565-572.
    >> Share

    August 2017
  76. MOYLAN DC, Pati SK, Ross SA, Fowler KB, et al
    Breast Milk HCMV viral load is associated with the establishment of breast milk CMV-pp65-specific CD8 T cells in Human CMV infected Mothers.
    J Infect Dis. 2017 Aug 29. doi: 10.1093.
    >> Share

    July 2017
  77. HENRICH TJ, Hobbs KS, Hanhauser E, Scully E, et al
    Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy.
    J Infect Dis. 2017;216:254-262.
    >> Share

    May 2017
  78. SCHOCH J, Rohrer TR, Kaestner M, Abdul-Khaliq H, et al
    Quantitative, Phenotypical, and Functional Characterization of Cellular Immunity in Children and Adolescents With Down Syndrome.
    J Infect Dis. 2017;215:1619-1628.
    >> Share

    April 2017
  79. FORMAN MS, Vaidya D D, Bolorunduro O, Diener-West M, et al
    Cytomegalovirus (CMV) kinetics following primary infection in healthy women.
    J Infect Dis. 2017 Apr 18. doi: 10.1093.
    >> Share

  80. YONG MK, Cameron PU, Slavin M, Morrissey CO, et al
    Identifying Cytomegalovirus (CMV) complications using the Quantiferon-CMV assay after Allogeneic Hematopoietic Stem Cell Transplantation.
    J Infect Dis. 2017 Apr 18. doi: 10.1093.
    >> Share

  81. TONG Y, Pang XL, Mabilangan C, Preiksaitis JK, et al
    Determination of the Biological Form of Human Cytomegalovirus DNA in the Plasma of Solid-Organ Transplant Recipients.
    J Infect Dis. 2017 Apr 12. doi: 10.1093.
    >> Share

    March 2017
  82. HAGE E, Wilkie GS, Linnenweber-Held S, Dhingra A, et al
    Characterization of human cytomegalovirus genome diversity in immunocompromised hosts by whole genomic sequencing directly from clinical specimens.
    J Infect Dis. 2017 Mar 27. doi: 10.1093.
    >> Share

  83. JANSEN MAE, van den Heuvel D, Jaddoe VWV, Moll HA, et al
    No Interactive Effects of Sex and Persistent Cytomegalovirus on Immune Phenotypes in Young Children: The Generation R Study.
    J Infect Dis. 2017;215:883-888.
    >> Share

  84. YOUNG VP, Mariano MC, Tu CC, Allaire KM, et al
    Modulation of the Host Environment by Human Cytomegalovirus with Viral Interleukin 10 in Peripheral Blood.
    J Infect Dis. 2017;215:874-882.
    >> Share

    February 2017
  85. MAECKER HT
    Opening the Door on the CMV Immune Response in Aging.
    J Infect Dis. 2017 Feb 12. doi: 10.1093.
    >> Share

  86. BAJWA M, Vita S, Vescovini R, Larsen M, et al
    CMV-specific T-cell responses at older ages: broad responses with a large central memory component may be key to long-term survival.
    J Infect Dis. 2017 Feb 12. doi: 10.1093.
    >> Share

  87. BOECKH M, Stevens-Ayers T, Travi G, Huang ML, et al
    Bronchoalveolar Lavage DNA Quantification in Cytomegalovirus Pneumonia after Hematopoietic Cell Transplantation.
    J Infect Dis. 2017 Feb 9. doi: 10.1093.
    >> Share

  88. GRIFFITHS P
    Diagnosis of cytomegalovirus pneumonitis following stem cell transplantation: addressing the Ying and Yang of molecular methods.
    J Infect Dis. 2017 Feb 9. doi: 10.1093.
    >> Share

  89. JANSEN MA, Heuvel DV, Jaddoe VW, Moll HA, et al
    Gender-specific differences in immune phenotypes of young children are not affected by persistent cytomegalovirus infection. The Generation R Study.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    >> Share

  90. YOUNG VP, Mariano MC, Tu CC, Allaire KM, et al
    Human Cytomegalovirus (HCMV) modulates the host environment with vIL-10 in peripheral blood.
    J Infect Dis. 2017 Feb 1. doi: 10.1093.
    >> Share

    December 2016
  91. EVANS C, Chasekwa B, Rukobo S, Govha M, et al
    CMV acquisition and inflammation in HIV-exposed uninfected Zimbabwean infants.
    J Infect Dis. 2016 Dec 23. pii: jiw630. doi: 10.1093.
    >> Share

  92. HAN SH, Kumar D, Ferreira VH, Egli A, et al
    Human microRNA responses predict cytomegalovirus replication following solid organ transplantation.
    J Infect Dis. 2016 Dec 21. pii: jiw596. doi: 10.1093.
    >> Share

  93. BIALAS KM, Westreich D, Cisneros de la Rosa E, Nelson CS, et al
    Maternal Antibody Responses and Nonprimary Congenital Cytomegalovirus Infection of HIV-1-Exposed Infants.
    J Infect Dis. 2016;214:1916-1923.
    >> Share

    October 2016
  94. SCHIRDEWAHN T, Grabowski J, Sekyere SO, Bremer B, et al
    The third signal cytokine IL-12 rather than immune checkpoint inhibitors contribute to the functional restoration of hepatitis D virus-specific T-cells.
    J Infect Dis. 2016.
    >> Share

  95. GIANELLA S, Letendre S
    Cytomegalovirus and HIV: A Dangerous Pas de Deux.
    J Infect Dis. 2016;214 Suppl 2:S67-74.
    >> Share

    September 2016
  96. MAYER BT, Matrajt L, Casper C, Krantz EM, et al
    Dynamics of persistent oral cytomegalovirus shedding during primary infection in Ugandan infants.
    J Infect Dis. 2016.
    >> Share

    May 2016
  97. DAUBY N, Sartori D, Kummert C, Lecomte S, et al
    Limited Effector Memory B-Cell Response to Envelope Glycoprotein B During Primary Human Cytomegalovirus Infection.
    J Infect Dis. 2016;213:1642-50.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016